Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100062032 | 10006203 | 2 | F | 2013 | 20150313 | 20140313 | 20150331 | EXP | US-ASTELLAS-2014US002488 | ASTELLAS | 85.24 | YR | M | Y | 0.00000 | 20150330 | N | CN | GB | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100062032 | 10006203 | 1 | PS | Erlotinib | ERLOTINIB | 1 | ORAL | 150 MG, 3 DAYS ON AND 1 DAY OFF | D | 82648P1CW | 21743 | 150 | MG | TABLET | |||||
100062032 | 10006203 | 2 | SS | Erlotinib | ERLOTINIB | 1 | D | 21743 | TABLET | ||||||||||
100062032 | 10006203 | 3 | C | ASPIRIN. | ASPIRIN | 1 | ORAL | UNK (4 IN 1 WK) | U | 0 | FORMULATION UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
100062032 | 10006203 | 1 | Lung neoplasm malignant |
100062032 | 10006203 | 2 | Lung neoplasm malignant |
100062032 | 10006203 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
100062032 | 10006203 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
100062032 | 10006203 | Computerised tomogram abnormal | |
100062032 | 10006203 | Dry skin | |
100062032 | 10006203 | Epistaxis | |
100062032 | 10006203 | Haemorrhagic diathesis | |
100062032 | 10006203 | Hearing impaired | |
100062032 | 10006203 | Hip fracture | |
100062032 | 10006203 | Hypertension | |
100062032 | 10006203 | Inappropriate schedule of drug administration | |
100062032 | 10006203 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |